Medicines Patent Pool Announces Sub-Licensing Agreements For Hepatitis C Generics
By Jahan ‘Harry’ Taubman-Rezakhanlou for Intellectual Property Watch The Medicines Patent Pool today announced its first round of sub-licensing agreements with four generic manufacturers for the production and sale of a generic line of Bristol-Myers Squibb’s daclatasvir to 112 lower-to…
